Jonathan Sterne

Sterne has been identified by Clarivate Analytics as a "Highly Cited Researcher" in the last three years,^[when?] based on multiple highly cited papers that rank in the top 1% by citations for field and year in Web of Science.^[3]

His research interests include methodology for systematic reviews and meta-analyses, clinical epidemiology of HIV and AIDS in the era of antiretroviral therapy, causal inference, methodology for epidemiology and health services research, and epidemiology of asthma and allergic diseases.^[1]

Sterne has led the development of the ROBINS-I tool for assessing risk of bias in non-randomized studies of interventions and the Cochrane Risk of Bias (RoB) tool for randomized trials. He also leads a large collaboration of HIV cohort studies, which has advanced understanding of prognosis in HIV positive people. He also authored a number of meta-analysis software routines used by students and researchers worldwide.^[4]

On 28 August 2019 Sterne, along with Julian Higgins and colleagues, published in The RoB 2 tool in the British Medical Journal, an updated version of the leading tool for assessing risk of bias in randomized trials included in systematic reviews.^[5]

Sterne completed his undergraduate studies in mathematics at the University of Oxford. He holds an MSc and PhD in statistics from the University College London.^[1]